+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 6Years +
All Genders
ID07904910

Comparing Crisaborole 2% Ointment and Tacrolimus 0.1% Ointment Combined with Excimer Light Therapy for Treating Stable Facial Vitiligo in Children and Adults

Led by Cairo University · Updated on 2026-10-29

35

Participants Needed

1

Research Sites

2 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating whether crisaborole 2% ointment can effectively treat stable patches of facial vitiligo in children and adults of all genders. This study also compares the safety and tolerability of crisaborole 2% ointment with tacrolimus 0.1% ointment in similar patients. The goal is to determine if crisaborole works as well as tacrolimus for stable localized facial vitiligo. Participants will be randomly assigned to one of two groups one applying crisaborole 2% ointment and the other applying tacrolimus 0.1% ointment. Both groups will apply their assigned ointment twice daily to the vitiligo patches on their face. In addition, all participants will undergo Excimer light therapy sessions twice a week for up to 6 months or until complete repigmentation occurs, whichever comes first. During the study, participants will visit the clinic twice weekly for Excimer light treatments, checkups, and photography sessions. They will also keep a diary to track their symptoms. Researchers will measure changes in vitiligo using the Facial Vitiligo Area Scoring Index and the Vitiligo Extent Score for a Target Area at the start, 12 weeks, and 24 weeks. Secondary measures include time to repigmentation onset, impact of vitiligo on quality of life, and patient satisfaction. The trial is expected to continue until November 2026.

CONDITIONS

Brief Title

Evaluation of Crisaborole 2% Versus Tacrolimus 0.1% Each Combined With Excimer Light in the Treatment of Stable Non-segmental Facial Vitiligo: a Prospective Randomized Controlled Study.

Research Team

R

Riham M Mohamed, MD, MSc., PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here